Wong RW - Search Results

1

Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.

Mok CC, Ho CT, Siu YP, Chan KW, Kwan TH, Lau CS, Wong RW, Au TC. Mok CC, et al. Among authors: wong rw. Am J Kidney Dis. 2001 Aug;38(2):256-64. doi: 10.1053/ajkd.2001.26084. Am J Kidney Dis. 2001. PMID: 11479150 Clinical Trial.

2

CD5-positive and CD5-negative plaque-forming cells against poly-L-lysine-treated sheep erythrocytes in patients with systemic lupus erythematosus.

Jones BM, Lau CS, Wong RW. Jones BM, et al. Among authors: wong rw. Autoimmunity. 1994;18(3):189-94. doi: 10.3109/08916939409007995. Autoimmunity. 1994. PMID: 7532018 Free article.

3

Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone.

Chan TM, Li FK, Wong RW, Wong KL, Chan KW, Cheng IK. Chan TM, et al. Among authors: wong rw, wong kl. Nephron. 1995;71(3):321-7. doi: 10.1159/000188739. Nephron. 1995. PMID: 8569982

4

Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.

Mok CC, Lau CS, Chan EY, Wong RW. Mok CC, et al. Among authors: wong rw. J Rheumatol. 1998 Mar;25(3):467-73. J Rheumatol. 1998. PMID: 9517765

5

Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.

Mok CC, Lau CS, Wong RW. Mok CC, et al. Among authors: wong rw. Arthritis Rheum. 1998 May;41(5):831-7. doi: 10.1002/1529-0131(199805)41:5<831::AID-ART9>3.0.CO;2-1. Arthritis Rheum. 1998. PMID: 9588734

6

Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases.

Mok CC, Lau CS, Wong RW. Mok CC, et al. Among authors: wong rw. J Rheumatol. 1998 Jun;25(6):1246-7. J Rheumatol. 1998. PMID: 9632100 No abstract available.

7

Kienbock's disease in rheumatoid arthritis.

Mok CC, Wong RW, Lau CS. Mok CC, et al. Among authors: wong rw. Br J Rheumatol. 1998 Jul;37(7):796-7. doi: 10.1093/rheumatology/37.7.796. Br J Rheumatol. 1998. PMID: 9714362 No abstract available.

8

Risk factors for avascular bone necrosis in systemic lupus erythematosus.

Mok CC, Lau CS, Wong RW. Mok CC, et al. Among authors: wong rw. Br J Rheumatol. 1998 Aug;37(8):895-900. doi: 10.1093/rheumatology/37.8.895. Br J Rheumatol. 1998. PMID: 9734682

9

Late onset systemic lupus erythematosus in southern Chinese.

Ho CT, Mok CC, Lau CS, Wong RW. Ho CT, et al. Among authors: wong rw. Ann Rheum Dis. 1998 Jul;57(7):437-40. doi: 10.1136/ard.57.7.437. Ann Rheum Dis. 1998. PMID: 9797573 Free PMC article.

10

Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus.

Mok CC, Lau CS, Ho CT, Lee KW, Mok MY, Wong RW. Mok CC, et al. Among authors: wong rw. Scand J Rheumatol. 1998;27(5):342-6. doi: 10.1080/03009749850154357. Scand J Rheumatol. 1998. PMID: 9808396 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters